Akari Therapeutics Plc
AKTX
←Back to Recent Filings
| Filing |
DATE |
FP |
FY |
End Date |
URL |
VIEW |
|
| 10-Q |
11/13/2025 |
Q3 |
2025 |
9/30/2025 |
SEC |
view |
|
| 10-Q |
8/13/2025 |
Q2 |
2025 |
6/30/2025 |
SEC |
view |
|
| WIREPR |
5/15/2025 |
Q1 |
2025 |
3/31/2025 |
WIRE |
view |
data |
| 8-K |
5/15/2025 |
Q1 |
2025 |
3/31/2025 |
SEC |
view |
data |
| 10-Q |
5/14/2025 |
Q1 |
2025 |
3/31/2025 |
SEC |
view |
|
| 8-K |
4/16/2025 |
Q1 |
2025 |
3/31/2025 |
SEC |
view |
data |
| 10-K |
4/15/2025 |
Q4 |
2024 |
12/31/2024 |
SEC |
view |
|
| 10-Q |
11/19/2024 |
Q3 |
2024 |
9/30/2024 |
SEC |
view |
|
| S-4/A |
10/9/2024 |
Q2 |
2024 |
6/30/2024 |
SEC |
view |
|
| S-4/A |
9/30/2024 |
Q2 |
2024 |
6/30/2024 |
SEC |
view |
|
| S-4 |
9/13/2024 |
Q2 |
2024 |
6/30/2024 |
SEC |
view |
|
| 10-Q |
8/19/2024 |
Q2 |
2024 |
6/30/2024 |
SEC |
view |
|
| 8-K |
8/19/2024 |
Q2 |
2024 |
6/30/2024 |
SEC |
view |
data |
| 8-K |
5/16/2024 |
Q1 |
2024 |
3/31/2024 |
SEC |
view |
data |
| 10-Q |
5/15/2024 |
Q1 |
2024 |
3/31/2024 |
SEC |
view |
|
| 8-K |
4/1/2024 |
Q4 |
2023 |
12/31/2023 |
SEC |
view |
data |
| 10-K |
3/29/2024 |
Q4 |
2023 |
12/31/2023 |
SEC |
view |
|
| WIREPR |
9/29/2023 |
Q2 |
2023 |
6/30/2023 |
WIRE |
view |
data |
| 6-K |
9/29/2023 |
Q2 |
2023 |
6/30/2023 |
SEC |
view |
|
| WIREPR |
5/1/2023 |
Q4 |
2022 |
12/31/2022 |
WIRE |
view |
data |
| 20-F |
5/1/2023 |
Q4 |
2022 |
12/31/2022 |
SEC |
view |
|
| WIREPR |
9/27/2022 |
Q2 |
2022 |
6/30/2022 |
WIRE |
view |
data |
| 6-K |
9/27/2022 |
Q2 |
2022 |
6/30/2022 |
SEC |
view |
|
| WIREPR |
7/20/2022 |
Q2 |
2022 |
6/30/2022 |
WIRE |
view |
data |
| WIREPR |
5/16/2022 |
Q4 |
2021 |
12/31/2021 |
WIRE |
view |
data |
| 20-F |
5/16/2022 |
Q4 |
2021 |
12/31/2021 |
SEC |
view |
|
| WIREPR |
12/3/2021 |
Q3 |
2021 |
9/30/2021 |
WIRE |
view |
data |
| WIREPR |
9/22/2021 |
Q2 |
2021 |
6/30/2021 |
WIRE |
view |
data |
| 6-K |
9/22/2021 |
Q2 |
2021 |
6/30/2021 |
SEC |
view |
|
| WIREPR |
6/29/2021 |
Q1 |
2021 |
3/31/2021 |
WIRE |
view |
data |
| 20-F |
4/21/2021 |
Q4 |
2020 |
12/31/2020 |
SEC |
view |
|
| WIREPR |
4/20/2021 |
Q4 |
2020 |
12/31/2020 |
WIRE |
view |
data |
| WIREPR |
12/11/2020 |
Q3 |
2020 |
9/30/2020 |
WIRE |
view |
data |
| WIREPR |
9/1/2020 |
Q2 |
2020 |
6/30/2020 |
WIRE |
view |
data |
| 6-K |
9/1/2020 |
Q2 |
2020 |
6/30/2020 |
SEC |
view |
|
| WIREPR |
5/29/2020 |
Q1 |
2020 |
3/31/2020 |
WIRE |
view |
data |
| WIREPR |
3/31/2020 |
Q4 |
2019 |
12/31/2019 |
WIRE |
view |
data |
| 20-F |
3/31/2020 |
Q4 |
2019 |
12/31/2019 |
SEC |
view |
|
| WIREPR |
11/4/2019 |
Q3 |
2019 |
9/30/2019 |
WIRE |
view |
data |
| WIREPR |
8/29/2019 |
Q2 |
2019 |
6/30/2019 |
WIRE |
view |
data |
| 6-K |
8/29/2019 |
Q2 |
2019 |
6/30/2019 |
SEC |
view |
|
| WIREPR |
5/29/2019 |
Q1 |
2019 |
3/31/2019 |
WIRE |
view |
data |
| WIREPR |
4/23/2019 |
Q4 |
2018 |
12/31/2018 |
WIRE |
view |
data |
| 20-F |
4/23/2019 |
Q4 |
2018 |
12/31/2018 |
SEC |
view |
|
| WIREPR |
11/15/2018 |
Q3 |
2018 |
9/30/2018 |
WIRE |
view |
data |
| 6-K |
9/27/2018 |
Q2 |
2018 |
6/30/2018 |
SEC |
view |
|
| WIREPR |
8/17/2018 |
Q2 |
2018 |
6/30/2018 |
WIRE |
view |
data |
| 20-F |
7/18/2018 |
Q4 |
2017 |
12/31/2017 |
SEC |
view |
|
| 6-K |
8/10/2017 |
Q2 |
2017 |
6/30/2017 |
SEC |
view |
|
| 6-K/A |
4/14/2017 |
Q2 |
2016 |
6/30/2016 |
SEC |
view |
|
| 20-F |
3/31/2017 |
Q4 |
2016 |
12/31/2016 |
SEC |
view |
|
| 10-Q |
5/12/2016 |
Q1 |
2016 |
3/31/2016 |
SEC |
view |
|
| 10-K |
3/23/2016 |
Q4 |
2015 |
12/31/2015 |
SEC |
view |
|
| 10-Q |
11/23/2015 |
Q3 |
2015 |
9/30/2015 |
SEC |
view |
|
| 10-Q |
8/12/2015 |
Q2 |
2015 |
6/30/2015 |
SEC |
view |
|
| 10-Q |
5/12/2015 |
Q1 |
2015 |
3/31/2015 |
SEC |
view |
|
| 10-K |
2/11/2015 |
Q4 |
2014 |
12/31/2014 |
SEC |
view |
|
| S-1 |
11/20/2014 |
Q3 |
2013 |
9/30/2014 |
SEC |
view |
|
| 20-F |
3/24/2014 |
Q4 |
2013 |
12/31/2013 |
SEC |
view |
|
| F-1/A |
1/7/2014 |
Q3 |
2013 |
9/30/2013 |
SEC |
view |
|
| F-1 |
10/24/2013 |
Q2 |
2013 |
6/30/2013 |
SEC |
view |
|
| 20-F/A |
4/19/2013 |
Q4 |
2012 |
12/31/2012 |
SEC |
view |
|